Evidence map›Paper›PMID 26231141›Full record

ArticlePharmaceutical research2016

A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the Lungs.

Swan Lin, Jennifer Racz, Melissa F Tai, Kristina M Brooks, Phillip Rzeczycki, Lauren J Heath, Michael W Newstead, Theodore J Standiford, Gus R Rosania, Kathleen A Stringer

Open access · greenAbstract read
In one paragraph

Article in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Swan LinDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Jennifer RaczDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Melissa F TaiDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Kristina M BrooksDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Phillip RzeczyckiDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Lauren J HeathDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Michael W NewsteadDivision of Pulmonary and Critical Care Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Theodore J StandifordDivision of Pulmonary and Critical Care Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Gus R RosaniaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Kathleen A StringerDepartment of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. stringek@umich.edu.ORCID http://orcid.org/0000-0003-0238-7774
University of Michigan · US

Funding

Chemical Address Tags: A Cheminformatics & Image Data Management and Analysis Plan - SupplementR01GM078200 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROSANIA, GUS R · 2006 to 2015
$4.2M
Safety of Lung Delivered Tissue Plasminogen ActivatorR42HL071439 · NHLBI · HTD BIOSYSTEMS, INC. · PI STRINGER, KATHLEEN A · 2005 to 2006
$833k
Pulmonary Formulation of tPA for Plastic BronchitisR15HD065594 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STRINGER, KATHLEEN A · 2010 to 2010
$463k
Lung Delivery of Nebulized Tissue Plasminogen ActivatorR41HL071439 · NHLBI · HTD BIOSYSTEMS, INC. · PI STRINGER, KATHLEEN A · 2003 to 2003
$100k
NHLBI NIH HHS HL071439NHLBI NIH HHS R41 HL071439NHLBI NIH HHS R42 HL071439NICHD NIH HHS HD065594NICHD NIH HHS R15 HD065594NIGMS NIH HHS GM078200NIGMS NIH HHS R01 GM078200
6 · The paper itself

Abstract

purposeTo gain knowledge of lung clearance mechanisms of inhaled tissue plasminogen activator (tPA).

methodsUsing an in vivo mouse model and ex vivo murine whole organ cell suspensions, we examined the capability of the lungs to utilize LRP1 receptor-mediated endocytosis (RME) for the uptake of exogenous tPA with and without an LRP1 inhibitor, receptor associated protein (RAP), and quantitatively compared it to the liver. We also used a novel imaging technique to assess the amount LRP1 in sections of mouse liver and lung.

resultsFollowing intratracheal administration, tPA concentrations in the bronchoalveolar lavage fluid (BALF) declined over time following two-compartment pharmacokinetics suggestive of a RME clearance mechanism. Ex vivo studies showed that lung and liver cells are similarly capable of tPA uptake via LRP1 RME which was reduced by ~50% by RAP. The comparable lung and liver uptake of tPA is likely due to equivalent amounts of LRP1 of which there was an abundance in the alveolar epithelium.

conclusionsOur findings indicate that LRP1 RME is a candidate clearance mechanism for inhaled tPA which has implications for the development of safe and effective dosing regimens of inhaled tPA for the treatment of plastic bronchitis and other fibrin-inflammatory airway diseases in which inhaled tPA may have utility.

Indexed as

AnimalsBronchoalveolar Lavage FluidEndocytosisEpitheliumInjections, SpinalIn Vitro TechniquesLiverLow Density Lipoprotein Receptor-Related Protein-1LungMaleMiceMice, Inbred C57BLPrimary Cell CultureReceptors, LDLTissue Plasminogen ActivatorTumor Suppressor ProteinsLow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseReceptors, LDLTissue Plasminogen ActivatorTumor Suppressor Proteinsplastic bronchitisreceptor mediated endocytosistherapeutic proteins

Identifiers

PMID26231141
PMCPMC4690798
OpenAlexW1041991323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.